1. Comparative analysis of the safety and efficacy of 1470-nm diode laser enucleation of the prostate and plasmakinetic resection of prostate in the treatment of large volume benign prostatic hyperplasia (>80 ml).
- Author
-
Xiao X, Maolin X, Tao X, Xiaohong D, Jinzhong W, Wei T, Gaoliang C, and Mengxi T
- Subjects
- Humans, Male, Follow-Up Studies, Lasers, Semiconductor adverse effects, Prostate surgery, Quality of Life, Treatment Outcome, Prostatic Hyperplasia surgery, Transurethral Resection of Prostate adverse effects
- Abstract
Objective: To compare the efficacy and safety of 1470-nm diode laser enucleation of the prostate (DiLEP) with that of plasmakinetic resection of the prostate (PKRP) in treating patients with large benign prostatic hyperplasia (BPH > 80ml)., Methods: The clinical data from 211 cases of BPH (>80 ml) were collected for analysis. The patients were divided into two groups: the PKRP group ( n = 118) and the DiLEP group ( n = 93), based on the surgical method used., Result: The DiLEP group demonstrated significantly lower surgical time ( p < 0.001), intraoperative bleeding ( p < 0.001), bladder flushing time ( p = 0.003), indwelling catheter time ( p < 0.005), and length of hospital stay ( p = 0.018) compared to the PKRP group. However, the quality of the prostatectomy was significantly higher in the DiLEP group ( p = 0.005). The Qmax for the DiLEP group was significantly higher than that of the PKRP group ( p < 0.05). Compared to the PKRP group, the incidence of urinary incontinence in the DiLEP group increased significantly 4 weeks post-surgery ( p = 0.026), although the need for blood transfusion during surgery was significantly reduced ( p = 0.037)., Conclusion: Both DiLEP and PKRP are safe and effective methods for treating large-volume BPH. However, DiLEP offers advantages such as more thorough glandular resection, shorter surgical time, reduced bleeding, quicker recovery, and fewer complications.
- Published
- 2024
- Full Text
- View/download PDF